Suppr超能文献

雄激素受体基因在滤泡性非霍奇金淋巴瘤中优先发生高甲基化。

The androgen receptor gene is preferentially hypermethylated in follicular non-Hodgkin's lymphomas.

作者信息

Yang Hongyu, Chen Chuan-Mu, Yan Pearlly, Huang Tim H-M, Shi Huidong, Burger Mattias, Nimmrich Inko, Maier Sabine, Berlin Kurt, Caldwell Charles W

机构信息

Department of Pathology and Anatomical Sciences, Fischel Cancer Center, University of Missouri School of Medicine, 115 Business Loop 70 West, Columbia, MO 65203, USA.

出版信息

Clin Cancer Res. 2003 Sep 15;9(11):4034-42.

Abstract

This investigation examined promoter DNA methylation of the androgen receptor (AR) gene in non-Hodgkin's lymphoma (NHL) representing different stages of B-cell differentiation. Steroid hormones are important endocrine messengers with a broad range of physiological functions, including regulation of B-cell lymphopoiesis. Some of these effects are mediated via specific receptors such as AR that can act as a ligand-dependent transcription factor for other genes. DNA was isolated from 76 NHL specimens representing pregerminal center, germinal center, and postgerminal center states of differentiation. Initial methylation data were obtained from oligonucleotide microarrays and was confirmed and extended using methylation-specific PCR. Methylation of the AR gene promoter was present in a nonrandom pattern. Those tumors derived from pregerminal center or postgerminal center stages showed virtually no methylation and expressed AR mRNA. Cases of germinal center origin, mainly follicular lymphomas and some diffuse large B-cell lymphomas, showed hypermethylation. Studies with NHL cell lines revealed that demethylation or reversal of histone deacetylation partially restored AR expression but reversal of both simultaneously provided a synergistic release from suppression. Promoter methylation of AR occurs in a differentiation stage-selective manner; those cases arising in the germinal center are preferentially methylated. Full re-expression of AR requires both demethylation and reacetylation, a finding that may affect treatment decisions.

摘要

本研究检测了代表B细胞分化不同阶段的非霍奇金淋巴瘤(NHL)中雄激素受体(AR)基因启动子的DNA甲基化情况。类固醇激素是重要的内分泌信使,具有广泛的生理功能,包括调节B细胞淋巴细胞生成。其中一些作用是通过特定受体介导的,如AR,它可以作为其他基因的配体依赖性转录因子。从76例代表生发中心前、生发中心和生发中心后分化状态的NHL标本中分离DNA。初始甲基化数据从寡核苷酸微阵列获得,并使用甲基化特异性PCR进行确认和扩展。AR基因启动子的甲基化呈非随机模式。那些源自生发中心前或生发中心后阶段的肿瘤几乎没有甲基化,并表达AR mRNA。生发中心起源的病例,主要是滤泡性淋巴瘤和一些弥漫性大B细胞淋巴瘤,表现为高甲基化。对NHL细胞系的研究表明,去甲基化或组蛋白去乙酰化的逆转部分恢复了AR表达,但两者同时逆转则提供了协同的抑制解除作用。AR启动子甲基化以分化阶段选择性方式发生;生发中心出现的那些病例优先发生甲基化。AR的完全重新表达需要去甲基化和重新乙酰化,这一发现可能会影响治疗决策。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验